Portfolio company
Exostemtech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops exosome-based therapeutics and production platforms for clinical researchers and healthcare providers treating intractable diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
EverZom
The company develops exosome-based regenerative therapies and a biomanufacturing platform for pharmaceutical laboratories, biotechnology firms, and cosmetics companies.
Evox Therapeutics
This biotechnology company develops engineered exosome therapeutics to deliver genetic medicines and proteins for patients with rare diseases and neurological disorders.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
EXO Therapeutics
This biotechnology company develops small-molecule drugs targeting enzyme exosites for healthcare institutions and pharmaceutical partners to treat oncology and inflammatory diseases.
Theratome Bio
This company develops stem-cell secretome therapeutics to treat ischemic brain injury, dry eye disease and organ transplant preservation for healthcare providers and patients.
Esphera SynBio
This synthetic biology company develops engineered exosome therapies to deliver therapeutic payloads for cancer and infectious disease treatments within the biopharmaceutical sector.
Theraport
Theraport develops engineered exosomes to facilitate the targeted delivery of drugs and genetic medicines for patients with complex diseases.
Aegle Therapeutics
This company develops extracellular vesicle therapies derived from stem cells to treat patients with rare dermatological disorders and severe burns.
